Physician profile
Devin Jagow
NPI 1508326141
$4,666.14
in general payments reported to CMS, 2019-2025
9 companies · $3,855 in 2025
The $3,855 reported for 2025 was more than what 92% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $811 · 2025: $3,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562 · Travel and Lodging: $2,049 · Education: $54.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,561.84 |
| Travel and Lodging | $2,049.34 |
| Education | $54.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,407.77 | 2024-2025 | Evoke |
| Si-Bone, INC. | $1,047.16 | 2025 | |
| Boston Scientific Corporation | $423.92 | 2024-2025 | General - Pain Management |
| Medtronic, INC. | $276.06 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Abbott Laboratories | $204.68 | 2024 | Proclaim |
| Mml US, INC. | $126.26 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $99.13 | 2024 | Sprint Pns System |
| Abbvie INC. | $54.96 | 2024 | |
| Spinal Simplicity, LLC | $26.20 | 2024 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Jagow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.